哮喘严重程度指数在潜在致命性哮喘患者中的应用。

The application of an asthma severity index in patients with potentially fatal asthma.

作者信息

Lowenthal M, Patterson R, Greenberger P A, Grammer L C

机构信息

Department of Medicine, Northwestern University Medical School, Chicago 60611.

出版信息

Chest. 1993 Nov;104(5):1329-31. doi: 10.1378/chest.104.5.1329.

DOI:10.1378/chest.104.5.1329

PMID:8222782

Abstract

The asthma severity index (ASI) is proposed as a tool to monitor the course of patients with increased risk of asthma-related morbidity and mortality. The ASI is a weighted summary of the diagnostic features of potentially fatal asthma (PFA). Fifteen patients with PFA were evaluated with ASIs calculated for the intervals 1 year prior to and 1 year following management by our allergy-immunology service. In each patient, a reduction was noted in the ASI following management, which corresponded to a reduction in asthma events. The ASI will have utility in the evaluation of chronic asthma treatment and in patient education.

摘要

哮喘严重程度指数（ASI）被提议作为一种监测哮喘相关发病率和死亡率风险增加患者病程的工具。ASI是潜在致命性哮喘（PFA）诊断特征的加权汇总。对15例PFA患者进行了评估，计算了我们过敏免疫科治疗前1年和治疗后1年期间的ASI。在每位患者中，治疗后ASI均有降低，这与哮喘发作次数的减少相对应。ASI将在慢性哮喘治疗评估和患者教育中发挥作用。